Interaction of 5,6- and 5,7-dihydroxytryptamine with tissue monoamine oxidase.
D015115:5,6-Dihydroxytryptamine / Q000378:metabolism / Q000494:pharmacology*; D015116:5,7-Dihydroxytryptamine / Q000378:metabolism / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000378:metabolism; D002855:Chromatography, Thin Layer; D004102:Dihydroxytryptamines / Q000494:pharmacology*; D005260:Female; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D007031:Hypothalamus / Q000378:metabolism; D066298:In Vitro Techniques; D007700:Kinetics; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors; D011485:Protein Binding; D051381:Rats; D012701:Serotonin / Q000494:pharmacology
D004102:Dihydroxytryptamines; D008996:Monoamine Oxidase Inhibitors; D015116:5,7-Dihydroxytryptamine; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D008995:Monoamine Oxidase; D015115:5,6-Dihydroxytryptamine